Akeva L.L.C. v. Nike, Inc., No. 19-2249 (Fed. Cir. July 16, 2020)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Akeva L.L.C. (Akeva) owns a portfolio of footwear pa- tents including U.S. Patent Nos. 5,560,126 (’126 patent); 6,966,130 (’130 patent); 7,114,269 (’269 patent); 5380,350 (’350 patent); and 7,540,099 (’099 patent); (collectively, the Asserted Patents). The ’130, ’269, ’350, and ’099 patents all claim priority to the ’126 patent and are referred to as the Continuation Patents. Asics filed for declaratory judg- ment that it does not infringe the Asserted Patents and, in response, Akeva countersued for patent infringement.